translation agency

AIDS Research and Therapy
Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy

<p>Brigitte E Sanders-Beer<sup>3,1*</sup>, Yvette Y Spano<sup>4</sup>, Dawn Golighty<sup>1</sup>, Abigail Lara<sup>1</sup>, Diane Hebblewaite<sup>1</sup>, Lourdes Nieves-Duran<sup>1</sup>, Lowrey Rhodes<sup>1</sup> and Keith G Mansfield<sup>2</sup></p>


January 21, 2011

Background

In many preclinical AIDS research studies, antiretroviral therapy (ART) is administered to experimentally simian immunodeficiency (SIV)-infected rhesus macaques for reduction of viral load to undetectable levels. Prolonged treatment of macaques with a high dose of PMPA (9-[2-(r)-(phosphonomethoxy) propyl] adenine or tenofovir; 30 mg/kg of body weight subcutaneously once daily) can result in proximal renal tubular dysfunction, a Fanconi-like syndrome characterized by glucosuria, aminoaciduria, hypophosphatemia, and bone pathology. In contrast, chronic administration of a low dose of PMPA (10 mg/kg subcutaneously once daily) starting at birth does not seem to be associated with any adverse health effects within 3 years of treatment. In contrast to PMPA, limited information on systemic toxicity in rhesus monkeys is available for FTC (5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; emtricitabine) and stavudine (d4T).

Results

In this study, the clinical and biochemical correlates of tubular nephrosis in SIV-infected rhesus macaques associated with systemic administration of high-dose ART consisting of the three nucleoside analog inhibitors PMPA, FTC, and d4T were investigated. It was found that acute renal failure was uncommon (7.1% of treated animals) and that morphologic evidence of nephropathy, which persisted for more than 300 days following discontinuation of the drug cocktail, was more frequent (52.4% of treated animals). While parameters from single time points lacked predictive value, biochemical alterations in Blood Urea Nitrogen (BUN) and phosphorus were frequently identified longitudinally in the blood of ART-treated animals that developed evidence of nephropathy, and these longitudinal changes correlated with disease severity.

Conclusions

Recommendations are proposed to limit the impact of drug-induced renal disease in future SIV macaque studies.

*Corresponding author: Brigitte E Sanders-Beer bsanders@bioqual.com

CLICK HERE FOR FULL-TEXT PDF OF JOURNAL ARTICLE

© 2011 Sanders-Beer et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



 





www.aegis.org